clinicians for influenza-like illness by state), as reported by the CDC and Prevention Surveillance Network. ... Influenza activity in the months before hospitalization was not associated with either outcome.
Baloxavir marboxil (Xofluza) to treat acute uncomplicated influenza in patients ages 12 years and older who have had symptoms for no more than 48 hours. ... The antiviral drug, taken as a single oral dose, is the first new antiviral flu treatment with a
The influenza vaccine formulation for the 2012-2013 season has been approved, the FDA announced last week. ... Based on virus samples and global disease patterns, the strains selected for inclusion in the 2012-2013 flu vaccines are:.
have the annual influenza vaccination, with exemptions allowed for medical contraindications or religious objections. ... Workers with an exemption must wear a mask during flu season every year.
Testing is not always necessary in all patients, especially in a community known to already be affected by influenza. ... clinical signs and symptoms of influenza,. prevalence of influenza in the population tested,.
Without those results, it's difficult to know whether a patient has flu, Dr. ... Babik said. Molecular assays, or polymerase chain reaction (PCR) tests, are 95% sensitive and specific for flu, and some can identify influenza A versus B or flu subtypes.
Researchers identified all influenza vaccinations administered at the hospital during the period of Aug. ... 1 to April 30 for influenza seasons 2011 to 2012, 2012 to 2013, and 2013 to 2014.
elderly and pregnant women, and eliminates the egg-allergy exception for influenza vaccines. ... All patients age six months and over should continue to be vaccinated against influenza.
A label change to note that Afluria influenza virus vaccine has been associated with an increased incidence of fever and febrile seizure among young children in Australia, mainly among those less ... Vaccines for the 2010-2011 influenza season in the
The Centers for Disease Control and Prevention last week issued recommendations on antiviral treatment for avian influenza A(H7N9). ... The CDC said that clinicians should consider H7N9 influenza in patients with acute febrile respiratory illness who